Regulatory Trends

CMS and ONC Interoperability Rules Will Affect You. Let Us Count the Ways.

By Gary Austin, Payer/Provider Interoperability Lead​ and Ken Kleinberg, Innovative Technologies Practice Lead Editor’s Note:  This blog was updated April 23, 2020 to reflect timeline updates made by CMS and …

How Can Stakeholders Respond to Federal Recommendations on the Use of Health IT to Reduce Physician Burden?

By Michael Burger, Practice Lead, EHRs and EDI Physicians today face many realities in their practices that often create frustration— burdensome administrative tasks, complex clinical care, tightened reimbursement, required quality …

Game Changer? Ciox Health Record Sharing Ruling Could Have Wide-Reaching Impact

By Tony Schueth, CEO & Managing Partner and Ken Kleinberg, Innovative Technologies Practice Lead Today’s news cycle is so short and fast that we can often overlook important developments. An …

Feds’ Year-End Guidance Will Affect Electronic Prescribing and EHRs

By Tony Schueth, CEO and Managing Partner The world of health IT was buzzing this week in the wake of a massive rule drop by the Office of the National …

POCP Responds to Proposed Regulation Requiring Adoption of Real-Time Pharmacy Benefit Check by Medicare Part D

By Tony Schueth, CEO and Managing Partner Medicare Part D could adopt the Real-Time Pharmacy Benefit Check (RTPBC) beginning as early as January 1, 2020. That is what’s proposed in …

Kicking Back the Anti-Kickback Rules for Patient Data Sharing?

By Michael Burger, Practice Lead, EHRs and EDI The government anti-kickback statute, aka the Stark legislation, prohibits physician ownership and involvement in certain kinds of healthcare activities. It’s long been …

State and Federal Regulations Continue to Target the Opioid Epidemic and Part D Prescribing

By Keith Fisher, R.Ph. and Michelle Soble, R.Ph. Co-Leads, POCP Regulatory Resource Center Opioid overdoses increased 30 percent from July 2016 through September 2017 in 52 areas in 45 states.¹ In …

New POCP Report Examines How States are Addressing Opioid Prescribing, A Root Cause of the Epidemic

By Tony Schueth A first-of-its kind report that details how states are fighting the opioid crisis at the prescription level has been developed by Point of Care Partners (POCP). Unlike …

Missouri Creates a Unique PDMP

By Connie Sinclair, Director, Regulatory Resource Center Until recently, Missouri was the only state without a Prescription Drug Monitoring Program (PDMP).  Growing evidence suggests that use of these state-run databases …

How Stakeholders are Affected by FDA’s New Naming Convention for Biologics and Biosimilars

By Pooja Babbrah, Senior Consultant Stakeholders across the industry are debating potential costs and burden associated with implementing the new, nonproprietary naming convention for biologics and biosimilars. Requirements for the …